The Materials Core (Biological Sample and Processing) is comprised ofthe Fred Hutchinson Cancer Research Center (FHCRC) and the Mayo Clinic Scottsdale. The two entities will be responsible for providing cell line and tissue reagents in support of all projects within the Center and will support the development of common reagents. Each project research plan requires well-characterized cell lines and primary tissues to further the experimental goals ofthe Center. The FHCRC portion ofthe Core will be under the direction of Dr. William Grady, who will manage the cell lines used in projects 1 through 3. The Mayo Clinic portion ofthe Core will be under the direction of Dr. Joseph Mikhaels, who will coordinate the collection and characterization of tissues. The cell lines that will be maintained and distributed to researchers are colon adenoma and adenocarcinoma and Barrett's Esophagus and esophageal adenocarcinoma cell lines. Primary tissue samples will be collected during endoscopy and colonoscopy following procedures approved by the Institutional Review Board at Mayo Clinic.

Public Health Relevance

This Core will provide experimental samples for all experiments designed and completed within the other projects of the Center. The projects will contribute to the overall understanding of cancer, which would not be possible without this Core. By providing samples of cancer for experimentation, the Core is directly and positively impacting progress made in cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA143862-05
Application #
8744855
Study Section
Special Emphasis Panel (ZCA1-SRLB-9 (O1))
Project Start
2013-09-01
Project End
2014-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
5
Fiscal Year
2013
Total Cost
$101,894
Indirect Cost
$26,204
Name
Arizona State University-Tempe Campus
Department
Type
DUNS #
943360412
City
Tempe
State
AZ
Country
United States
Zip Code
85287
Yu, Ming; Heinzerling, Tai J; Grady, William M (2018) DNA Methylation Analysis Using Droplet Digital PCR. Methods Mol Biol 1768:363-383
Morris, Shelli M; Davison, Jerry; Carter, Kelly T et al. (2017) Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms. Int J Cancer 140:853-863
Yuan, Zixu; Baker, Kelsey; Redman, Mary W et al. (2017) Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer. Br J Cancer 117:1202-1210
Senapati, Subhadip; Lindsay, Stuart (2016) Recent Progress in Molecular Recognition Imaging Using Atomic Force Microscopy. Acc Chem Res 49:503-10
Bosch, Linda J W; Luo, Yanxin; Lao, Victoria V et al. (2016) WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy. Clin Cancer Res 22:4612-22
Al Mamun, Mohammed; Albergante, Luca; Moreno, Alberto et al. (2016) Inevitability and containment of replication errors for eukaryotic genome lengths spanning megabase to gigabase. Proc Natl Acad Sci U S A 113:E5765-74
Staunton, Jack R; Doss, Bryant L; Lindsay, Stuart et al. (2016) Correlating confocal microscopy and atomic force indentation reveals metastatic cancer cells stiffen during invasion into collagen I matrices. Sci Rep 6:19686
Cohen, Stacey A; Wu, Chen; Yu, Ming et al. (2016) Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin. Clin Colorectal Cancer 15:164-9
Navaei, Ali; Saini, Harpinder; Christenson, Wayne et al. (2016) Gold nanorod-incorporated gelatin-based conductive hydrogels for engineering cardiac tissue constructs. Acta Biomater 41:133-46
Nandakumar, Vivek; Hansen, Nanna; Glenn, Honor L et al. (2016) Vorinostat differentially alters 3D nuclear structure of cancer and non-cancerous esophageal cells. Sci Rep 6:30593

Showing the most recent 10 out of 54 publications